PMID- 1511163 OWN - NLM STAT- MEDLINE DCOM- 19920929 LR - 20071115 IS - 0925-5710 (Print) IS - 0925-5710 (Linking) VI - 55 IP - 2 DP - 1992 Apr TI - Identification and characterization of specific receptors for the LD78 cytokine. PG - 131-7 AB - LD78 is a small secreted protein that has a sequence similar to a number of other polypeptides, including murine macrophage inflammatory protein 1 alpha (MIP-1 alpha), interleukin 8 (IL-8), Act-2, monocyte chemoattractant protein 1 (MCP-1), and others. These polypeptides are members of a novel cytokine superfamily that is involved in the inflammatory response, wound healing, hematopoiesis, and tumorigenesis. Specific receptors for purified clonal LD78 protein were measured using four cell lines (HL-60, U937, Jurkat, and MJ). 125I-labeled recombinant LD78 bound most efficiently to U937 cells. We therefore characterized the receptors as being on the surface of U937 cells. Binding reached an equilibrium after incubation for 60 min at 4 degrees C. Scatchard analysis showed that there were two classes of binding sites on U937 cells, high affinity sites (Kd = 5.3 x 10(-9) M) and low affinity sites (Kd = 9.3 x 10(-8) M), with the average number of binding sites per cell being approximately 30,000 and approximately 90,000, respectively. These receptors for LD78 were distinct from the receptors for gamma-IFN and for IL-8. SDS-PAGE analysis of chemically crosslinked 125I-labeled LD78 receptor complexes identified a single band of 52 kDa. The ability to detect specific LD78 receptors should prove valuable in efforts to molecularly clone these receptors and to dissect the biological actions of LD78. FAU - Yamamura, Y AU - Yamamura Y AD - Second Department of Internal Medicine, Kumamoto University Medical School, Japan. FAU - Hattori, T AU - Hattori T FAU - Ohmoto, Y AU - Ohmoto Y FAU - Takatsuki, K AU - Takatsuki K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Int J Hematol JT - International journal of hematology JID - 9111627 RN - 0 (Chemokine CCL3) RN - 0 (Chemokine CCL4) RN - 0 (Cross-Linking Reagents) RN - 0 (Cytokines) RN - 0 (Macrophage Inflammatory Proteins) RN - 0 (Monokines) RN - 0 (Neoplasm Proteins) RN - 0 (Receptors, Chemokine) RN - 0 (Receptors, Immunologic) RN - 0 (Recombinant Proteins) RN - 0 (macrophage inflammatory protein 1alpha receptor) SB - IM MH - Chemokine CCL3 MH - Chemokine CCL4 MH - Cross-Linking Reagents/pharmacology MH - Cytokines/*metabolism MH - Hematopoietic Stem Cells/metabolism MH - Humans MH - Macrophage Inflammatory Proteins MH - Monokines/*metabolism MH - Neoplasm Proteins/*metabolism MH - Neoplastic Stem Cells/metabolism MH - *Receptors, Chemokine MH - Receptors, Immunologic/drug effects/*metabolism MH - Recombinant Proteins/metabolism MH - Tumor Cells, Cultured/metabolism EDAT- 1992/04/01 00:00 MHDA- 1992/04/01 00:01 CRDT- 1992/04/01 00:00 PHST- 1992/04/01 00:00 [pubmed] PHST- 1992/04/01 00:01 [medline] PHST- 1992/04/01 00:00 [entrez] PST - ppublish SO - Int J Hematol. 1992 Apr;55(2):131-7.